当前位置:
X-MOL 学术
›
Pacing Clin. Electrophysiol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Impact of different selection policies on subcutaneous ICD implants and therapies.
Pacing and Clinical Electrophysiology ( IF 1.7 ) Pub Date : 2020-05-08 , DOI: 10.1111/pace.13936 Idris Harding 1 , Amit Kaura 2 , Arthur Yue 3 , Paul Roberts 3 , Francis Murgatroyd 1 , Paul A Scott 1
Pacing and Clinical Electrophysiology ( IF 1.7 ) Pub Date : 2020-05-08 , DOI: 10.1111/pace.13936 Idris Harding 1 , Amit Kaura 2 , Arthur Yue 3 , Paul Roberts 3 , Francis Murgatroyd 1 , Paul A Scott 1
Affiliation
Patients with existing or anticipated indications for cardiac resynchronisation therapy (CRT), bradycardia, or anti‐tachycardia pacing should not be offered subcutaneous defibrillators (SQIDs) but it remains unclear how clinicians should predict future need for these therapies.
中文翻译:
不同选择政策对皮下 ICD 植入物和治疗的影响。
现有或预期有心脏再同步治疗 (CRT)、心动过缓或抗心动过速起搏适应症的患者不应使用皮下除颤器 (SQID),但目前尚不清楚临床医生应如何预测未来对这些治疗的需求。
更新日期:2020-05-08
中文翻译:
不同选择政策对皮下 ICD 植入物和治疗的影响。
现有或预期有心脏再同步治疗 (CRT)、心动过缓或抗心动过速起搏适应症的患者不应使用皮下除颤器 (SQID),但目前尚不清楚临床医生应如何预测未来对这些治疗的需求。